SELLAS Life Sciences (SLS) Operating Leases (2019 - 2024)
Historic Operating Leases for SELLAS Life Sciences (SLS) over the last 6 years, with Q3 2024 value amounting to $576000.0.
- SELLAS Life Sciences' Operating Leases fell 1055.9% to $576000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $576000.0, marking a year-over-year decrease of 1055.9%. This contributed to the annual value of $460000.0 for FY2023, which is 1972.08% down from last year.
- SELLAS Life Sciences' Operating Leases amounted to $576000.0 in Q3 2024, which was down 1055.9% from $692000.0 recorded in Q2 2024.
- SELLAS Life Sciences' 5-year Operating Leases high stood at $1.2 million for Q1 2022, and its period low was $123000.0 during Q1 2020.
- In the last 5 years, SELLAS Life Sciences' Operating Leases had a median value of $825000.0 in 2020 and averaged $789263.2.
- Per our database at Business Quant, SELLAS Life Sciences' Operating Leases crashed by 7388.54% in 2020 and then surged by 67154.47% in 2021.
- Over the past 5 years, SELLAS Life Sciences' Operating Leases (Quarter) stood at $825000.0 in 2020, then dropped by 26.06% to $610000.0 in 2021, then decreased by 6.07% to $573000.0 in 2022, then fell by 19.72% to $460000.0 in 2023, then increased by 25.22% to $576000.0 in 2024.
- Its last three reported values are $576000.0 in Q3 2024, $692000.0 for Q2 2024, and $801000.0 during Q1 2024.